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Tripartite motif-containing protein 32 (TRIM32) is a member 
of the TRIM ubiquitin E3 ligases which ubiquitinates different 
substrates in muscle including sarcomeric proteins. Mutations 
in TRIM32 are associated with Limb-Girdle Muscular Dys-
trophy 2H. In a 66 old woman with disto-proximal myopathy, 
we identified a novel homozygous mutation of TRIM32 gene 
c.1781G  >  A (p. Ser594Asn) localised in the c-terminus NHL 
domain. Mutations of this domain have been also associated 
to Sarcotubular Myopathy (STM), a form of distal myopathy 
with peculiar features in muscle biopsy, now considered in the 
spectrum of LGMD2H. Muscle biopsy revealed severe abnor-
malities of the myofibrillar network with core like areas, lobu-
lated fibres, whorled fibres and multiple vacuoles. Desmin and 
Myotilin stainings also pointed to accumulation as in Myofi-
brillar Myopathy. This report further confirms that STM and 
LGMD2H represent the same disorder and suggests to consider 
TRIM32 mutations in the genetic diagnosis of Sarcotubular 
Myopathy and Myofibrillar Myopathy.
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Introduction
The TRIM32 gene is composed of two exons encod-
ing for a protein of 653 amino acids which is a member of 
the TRIM ubiquitin E3 ligases. TRIM32 is characterized 
by a N-terminal conserved motif composed of a RING 
domain followed by a B-box and a Coiled-Coil domain, 
while its C-terminal portion presents 6 NHL repeats (1). 
The RING domain confers E3 ligase activity to TRIM32, 
the B-box and Coiled-Coil domains help the correct fold-
ing of the protein and the C-terminal domain mediates the 
interaction of TRIM32 with its substrates. The main role 
of TRIM32 consists in ubiquitination of different specific 
substrates (2, 3). Among these are included many muscu-
lar proteins such as actin, alpha-actinin, desmin, tropo-
myosin and dysbindin, thus indicating a role of TRIM32 
in promoting ubiquitin-dependent degradation of target 
proteins. Interestingly, TRIM32 was reported to localize 
around the Z-line in skeletal muscle of guinea pig, show-
ing a potential role of TRIM32 in the maintenance and 
physiology of the sarcomere  (4). Nevertheless TRIM32 
is involved in ubiquitination of cell cycle regulators (c-
Myc, MYCN, p53) and the cell growth and transforma-
tion factor, Abi2 (5, 6), involving TRIM32 in other signal-
ing mechanisms such as the regulation of muscle satellite 
cells renewal and differentiation.
TRIM32 mutations were initially described in the 
Manitoba Hutterite population (41 patients) of North 
America presenting with a LGMD2H phenotype and 
the first mutation identified was the c.1459G > A (p. As-
p487Asn) (7). LGMD2H is an autosomic recessive limb 
girdle muscular dystrophy associated with mildly to mod-
erately increased creatine kinase (CK), presenting with a 
wide clinical presentation spectrum, ranging from virtu-
ally asymptomatic patients to rarely wheelchair-bound in 
the late course of their disease. The same mutation re-
ported by Frosk et al. (7) was also identified in four pa-
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tients, affected by Sarcotubular Myopathy (STM), a form 
of autosomal recessive myopathy (8). Schoser et al.  (8) 
hypothesized that STM and LGMD2H represent differ-
ent severity presentations of the same disease, since STM 
and LGMD2H present with clinical and histological over-
lapping findings. Later, additional mutations in TRIM32 
has been identified in LGMD2H patients of non-Hutterite 
origins (9-14).
Patients harbouring mutations in TRIM32 share com-
mon features at muscle biopsy, such as increased fiber size 
variation, marked increase of internal nuclei and typical 
small, irregularly slit-shaped vacuoles that appeared emp-
ty. Electron microscopy showed the vacuoles to originate 
from focal dilations of the sarcoplasmic reticulum. The 
membranes limiting the vacuoles also showed sarcoplas-
mic reticulum-associated ATPase reactivity, confirming 
that the vacuoles arose from the cytoplasmatic organelles. 
In some muscle fibres small vacuoles were tightly packed 
and the membranes were partially disrupted resulting in 
larger vacuoles. Based on these findings muscle biopsies 
from patients with mutations in TRIM32 gene have been 
defined as Sarcotubular Myopathy pattern (8, 15-18). Oc-
casionally mild increase of endomysial fibrous connective 
tissue, necrotic fibers and fiber splitting were also reported. 
In two further reports, authors defined unspecific findings 
at muscle biopsy with no signs of sarcotubular aggregates 
in patients with TRIM2 gene mutations (12, 14).
The present work describes the clinical, histological 
and radiological features of a LGMD2H patient due to a 
novel homozygous mutation in the TRIM32 gene with a 
typical Sarcotubular Myopathy pattern at muscle biopsy.
Case report
The proposita, a 66-year- old woman, was the second 
child of healthy unrelated parents. She was born at term 
after uneventful pregnancy and normal delivery. Psycho-
motor development was reported normal and she did not 
refer motor defects during her childhood nor early adult-
hood.
At 40 years she incidentally documented a moderate 
hyperckemia (4X) without any muscle symptoms. When 
she was 46 years old she showed proximal weakness, par-
ticularly at the pelvic girdle, leading to weakness while 
climbing stairs. In the following 20 years she presented 
with a slowly progressive lower limb girdle muscle weak-
ness, being the upper limb performances less affected. 
She has never complained about respiratory symptoms 
nor cardiological involvement occurred.
At 49 years, a muscle biopsy from quadricep was 
performed, which revealed severe abnormalities of the 
Figure 1. Muscle biopsy. a-c) Representative images of H&E (a), NADH (b) and COX (c) stainings from patient muscle 
biopsy are shown. Lobulated fibres, whorled fibres and multiple vacuoles containing amorphous material are evident. In 
small boxes pictures from a normal control biopsy with the same staining are presented for comparison.
Figure 2. Muscle MRI. Muscle MRI of lower limbs 
showed a severe involvement of adductors longus, mag-
no and brevis (Score 4), glutei and tight posterior mus-
cles (Score 3).
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myofibrillar network with core-like areas, lobulated fi-
bres, whorled fibres and multiple vacuoles containing 
amorphous material (Fig. 1a-c). The histological findings 
pointed out a sarcotubular myofibrillar disorder.
Latest neurological examination at the age 66 showed 
minimal hypotrophy at scapular girdle muscles without 
muscle strength impairment, pelvic girdle muscle weak-
ness (quadriceps MRC 4, adductors MRC 3), waddling 
gait aided with a stick. Deep tendon reflexes were reduced 
in all limbs. Pseudo-hypertrophy of calves was evident. 
Rigid spine was also noted. Respiratory muscles function 
was spared with normal spirometry. Lower limb muscle 
MRI was performed at 64 years according to the protocol 
previously described (19). The MRI disclosed complete 
atrophy and fat substitution of adductors longus, magnus 
and brevis (Goutallier score  4), severe involvement of 
glutei and hamstrings muscles (Goutallier score  3) and 
a selective sparing of gracilis, sartorius and quadriceps 
muscles (Goutallier Score 2) (Fig. 2).
Recently this case was included in a group of undi-
agnosed muscular dystrophy patients to be analyzed by 
Limb Girdle Panel, an extended NGS testing panel which 
investigates the coding regions of 44 genes linked to LG-
MDs. We identified a novel homozygous mutation of 
TRIM32, NM_012210.3: c.1781G  >  A, (p. Ser594Asn) 
c.1781G  >  A/p.Ser594Asn, localized in the C-terminus 
NHL domain. Unfortunately patient’s parents were not 
available for segregation study. Thus, to exclude a pos-
sible deletion of the second allele as previously report-
ed (17) we performed qualitative and quantitative analy-
sis of TRIM32 cDNA and we didn’t identify alternative 
transcripts. (data not shown). 
The molecular model of TRIM32 refined with 
YASARA (Yet Another Scientific Artificial Reality Ap-
plication; www.yasara.org) showed that this mutation al-
ters specifically the correct conformation of the NHL do-
main (Fig. 3a). Mutations of this domain have been also 
associated to Sarcotubular Myopathy (STM), a form of 
distal myopathy with peculiar features in muscle biopsy, 
now considered in the spectrum of LGMD2H.
Since different muscular-relevant proteins have been 
identified as TRIM32 substrates, Desmin and Myotilin 
stainings were performed and the results pointed to ac-
cumulation of these proteins within the muscle fibers 
(Fig. 3b-c). Furthermore, Western blot analysis with anti-
TRIM32 antibody showed a modest reduction of TRIM32 
expression compared to the control (Fig. 3d).
Discussion
We describe a novel mutation in TRIM32 gene in 
an adult patient who presented with a mild limb girdle 
muscle weakness without respiratory nor cardiac involve-
ment. Muscle biopsy was suggestive of sarcotubular myo-
pathy or myofibrillar myopathy. MRI findings are similar 
to those described in literature (12, 14), showing a pref-
erential affection of the posterior thigh compartment with 
the sparing of sartorius, gracilis and the adductor longus.
Recently Johnson et al.  (14) described 9 patients 
carrying pathogenetic mutations in TRIM32. Muscle 
biopsies showed non-specific myopathic or dystrophic 
changes in most patients, whereas scattered vacuoles 
were noted only in 3 cases. These were described as 
rimmed vacuoles containing basophilic membranes. Our 
patient, dissimilarly from this report, displays mainly 
myofibrillar network abnormalities with core-like areas, 
lobulated fibers, whorled fibers. Additionally, multiple 
Figure 3. TRIM32 and its substrates. a) TRIM32 mod-
eling of WT and mutated protein was performed YASARA. 
Mutation p.Ser594Asn alters specifically the correct con-
formation of the NHL domain. b-c) Desmin and Myotilin 
stainings pointed out accumulation of these proteins 
within the muscle fibers. In small boxes pictures from a 
normal control biopsy immunofluorescence with same 
antibody d) TRIM32 protein levels were analyzed by 
Western blot. In the patient, the amount of TRIM32 protein 
in muscle was only slightly reduced compared to control
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large vacuoles containing amorphous material/deposits 
similar to cytoplasmic hyaline bodies or spheroid bodies 
are present.
Interesting, spheroids bodies have been described in 
association with myotilin mutations (20) and a myotilin 
defect is also responsible of a form of Myofibrillar Myo-
pathy. Hyaline bodies myopathies is a blurred definition 
of pathology alterations that, over the years, has been 
linked to mutations in several genes such as MYH7 in 
the form of myosin storage myopathy and FHL1 in the 
form of reducing bodies. In the whole, these myopathies 
with spheroid bodies, hyaline bodies but also cap and 
cytoplasmic bodies, have been referred as Surplus Pro-
tein Myopathies indicating an excess of proteins present 
in a granular or filamentous form  (21). In this scenario 
we speculate that the mutation here described abolishes 
the interaction between TRIM32 and its target proteins, 
which leads to a decreased ubiquitination and degrada-
tion by the proteasome machinery, thus inducing their 
accumulation to greater concentrations in the cytoplasm. 
To our knowledge, this is the first report which identi-
fied some of the proteins accumulated in the vacuoles in 
patient with TRIM32 mutation. Indeed, immunostain-
ings for Desmin and Myotilin, which are substrates of 
the TRIM32 E3 ligase, pointed to their accumulation in 
the cytoplasm. We interpreted these findings as result of 
altered ubiquitination of these proteins which are known 
substrates of TRIM32.
Furthermore our patient, harbouring a mutation local-
ized in the NHL domain, strengthens the previous findings 
according to which all the point mutations associated with 
LGMD2H are clustered in the C-terminus NHL domain, 
thus indicating a possible specific activity/property intrin-
sic to the NHL domain in the muscular tissue. The NHL 
domain is postulated to be critical for the recognition of 
protein targets to be ubiquitinated by this E3 ligase.
In conclusion, this report further confirms that STM 
and LGMD2H represent the same disorder and suggests 
to consider TRIM32 mutations in the genetic diagnosis of 
Sarcotubular Myopathies and Myofibrillar Protein Myo-
pathies. We also provided evidence that Desmin and My-
otilin represent the contents of the vacuoles in a muscle 
biopsy from a TRIM32 mutated patient.
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